Medical lab operator Quest Diagnostics Inc. said Monday it is selling the OVA1 blood test, which aims to better assess a woman's likelihood for ovarian cancer. The OVA1 test, which was approved by the Food and Drug Administration in September, will be sold through Quest, based in Madison ...

NEW YORK (Reuters Health) - People with Parkinson's disease face an increased risk of the most deadly type of skin cancer, new research confirms. Exams of more than 2,000 people with Parkinson's disease found that about 1 percent currently had melanoma, Dr. John M. Bertoni of the University of Nebraska Medical Center in Omaha and his colleagues found ...

NEW YORK (Reuters Health) - New research suggests that the type of specialist a prostate cancer patient sees -- rather than the patient's own preference -- may determine the treatment he receives. This is problematic, the study's authors say, because none of the options now available for treating localized prostate cancer have been shown to be any better than the others ...

NEW YORK (Reuters Health) - Women infected with HIV or at risk of becoming infected with HIV, the virus that causes AIDS, appear more likely to develop lung cancer than women in the general population, possibly because they are much more likely to smoke cigarettes, study findings hint. People with HIV have a much higher risk for many cancers. Still, it ...